Processing

Please wait...

Settings

Settings

Goto Application

Offices all Languages Stemming false Single Family Member true Include NPL false
RSS feed can only be generated if you have a WIPO account

Save query

A private query is only visible to you when you are logged-in and can not be used in RSS feeds

Query Tree

Refine Options

Offices
All
Specify the language of your search keywords
Stemming reduces inflected words to their stem or root form.
For example the words fishing, fished,fish, and fisher are reduced to the root word,fish,
so a search for fisher returns all the different variations
Returns only one member of a family of patents
Include Non-Patent literature in results

Full Query

IC:A61K36/00

Side-by-side view shortcuts

General
Go to Search input
CTRL + SHIFT +
Go to Results (selected record)
CTRL + SHIFT +
Go to Detail (selected tab)
CTRL + SHIFT +
Go to Next page
CTRL +
Go to Previous page
CTRL +
Results (First, do 'Go to Results')
Go to Next record / image
/
Go to Previous record / image
/
Scroll Up
Page Up
Scroll Down
Page Down
Scroll to Top
CTRL + Home
Scroll to Bottom
CTRL + End
Detail (First, do 'Go to Detail')
Go to Next tab
Go to Previous tab

Analysis

1.WO/2022/105726PRODUCTION METHOD FOR LYCOPENE-CONTAINING GRANULES WITH EFFICIENT ANTIOXIDATION EFFECT
WO 27.05.2022
Int.Class A61K 9/16
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
14Particulate form, e.g. powders
16Agglomerates; Granulates; Microbeadlets
Appl.No PCT/CN2021/130819 Applicant ZHONGKE HEALTH INDUSTRY GROUP CORP., LTD. Inventor FENG, Peng
A production method for lycopene-containing granules with an efficient antioxidation effect. The method comprises: extracting Ganoderma lucidum spore oil from Ganoderma lucidum spore powder having a broken sporoderm rate of 90%-92% by means of a CO2 supercritical extraction process to obtain degreased Ganoderma lucidum spore powder; and mixing the degreased Ganoderma lucidum spore powder and lycopene oil resin at a weight ratio of (1-2):(1-2), and performing spray granulation on same. In a granular product prepared by using the method, the effective component content is high, the lycopene content is more than 6%, and the polysaccharide content is more than 0.8%; and the product has good stability and has an efficient antioxidation effect.
2.WO/2022/104712COMPOUND COMPOSITION HAVING EFFECT OF PROMOTING BONE HEALTH, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
WO 27.05.2022
Int.Class A61K 38/01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
01Hydrolysed proteins; Derivatives thereof
Appl.No PCT/CN2020/130483 Applicant CHENLAND NUTRITIONALS, INC. Inventor ZOU, Shengcan
A compound composition having the effect of promoting bone health, which consists of a traditional Chinese medicine extract, chicken cartilage collagen, magnesium, vitamin K2 and vitamin D3. The traditional Chinese medicine extract is a mixture of a Eucommia ulmoides extract, a Davallia mariesii extract and a Cuscuta chinensis Lam. extract, and the traditional Chinese medicine extract is obtained by heating, refluxing and extracting with ethanol. The present invention also relates to a preparation method for the compound composition and an application thereof in the preparation of health foods.
3.WO/2022/109092SAFFRON AS ANTI-INFLAMMATORY AGENT IN TREATING INFLAMMATORY BOWEL DISEASE
WO 27.05.2022
Int.Class A61K 36/185
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
Appl.No PCT/US2021/059830 Applicant HOWARD UNIVERSITY Inventor ASHKTORAB, Hassan
A method for treating or mitigating Inflammatory bowel disease (IBD), particularly ulcerative colitis, including administering an effective amount of saffron to a subject in need thereof. A novel treatment in IBD, particularly ulcerative colitis, is thus provided.
4.WO/2022/107081METHODS OF TREATING AND PREVENTING INFECTIONS OF CORONAVIRUS AND OTHER INDICATIONS, AND COMPOSITIONS FOR USE WITH SAME
WO 27.05.2022
Int.Class A61K 36/24
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
24Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
Appl.No PCT/IB2021/060772 Applicant MIIPO, Pentibo Nagaipe Baihua Inventor MIIPO, Pentibo Nagaipe Baihua
Disclosed herein are compositions and methods for treating one or more symptoms of viral infection or preventing same. The disclosed compositions may include natural or synthetic compounds that are the similar or the same as compounds found in one or more plants or trees of Ecuador. In many embodiments, the one or more plants or trees are selected from Balsamo tree, Canaleta tree, Ajo de Monte, and Uña de Gato.
5.WO/2022/107095METHODS AND COMPOSITIONS FOR TREATING PAIN WITH 2-BROMO-LYSERGIC ACID DIETHYLAMIDE AND THYMOQUINONE
WO 27.05.2022
Int.Class A61K 31/48
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
47Quinolines; Isoquinolines
48Ergoline derivatives, e.g. lysergic acid, ergotamine
Appl.No PCT/IB2021/060823 Applicant HAVN LIFE SCIENCES INC. Inventor SAAD, Fadia
Disclosed are methods of treating pain, such as headaches, comprising administering an ergotamine and thymoquinone, wherein the ergotamine is selected from the group consisting of BOL-148, lysergic acid diethylamide (LSD), and lysergic acid amide (LSA). Also disclosed are pharmaceutical composition comprising an ergotamine and thymoquinone, wherein the ergotamine is selected from the group consisting of BOL-148, lysergic acid diethylamide (LSD), and lysergic acid amide (LSA).
6.WO/2022/108595IMPROVED OMEGA-3 CONTAINING COMPOSITIONS
WO 27.05.2022
Int.Class C11B 1/04
CCHEMISTRY; METALLURGY
11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
BPRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
1Production of fats or fatty oils from raw materials
02Pretreatment
04of vegetable raw material
Appl.No PCT/US2020/061561 Applicant NOOTER/ERIKSEN, INC. Inventor GOODALL, Brian L.
The present disclosure relates to a bioavailable, oil composition wherein at least 20% by weight% of its total lipids content comprises polar lipids such as glycolipids or phospholipids, at least 30 weight% of its polar lipids comprises glycolipids, and no more than 4% by weight% of the oil composition is made up of chlorophyll species. Formulations containing and methods for producing said oil compositions from algal oils or extracts are also disclosed.
7.WO/2022/107093COMPOSITION COMPRISING NATURAL EXTRACTS AND USES THEREOF
WO 27.05.2022
Int.Class A61K 36/752
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
75Rutaceae (Rue family)
752Citrus, e.g. lime, orange or lemon
Appl.No PCT/IB2021/060817 Applicant ESSERRE PHARMA SRL Inventor RICCIONI, Costanza Valentina
The present invention relates to a composition consisting of one or more plant extracts and comprising a flavanones content of at least 40% by weight with respect to the total weight of the composition.
8.WO/2022/106718METHOD FOR OBTAINING AQUEOUS EXTRACTS OF TEA LEAVES, COMPOSITIONS COMPRISING SUCH EXTRACTS AND COSMETIC USES THEREOF
WO 27.05.2022
Int.Class A61K 8/9789
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
8Cosmetics or similar toilet preparations
18characterised by the composition
96containing materials, or derivatives thereof, of undetermined constitution
97from algae, fungi, lichens or plants; from derivatives thereof
9783Angiosperms
9789Magnoliopsida
Appl.No PCT/EP2021/082631 Applicant ISP INVESTMENTS LLC Inventor OGER, Elodie
The invention relates to a method for obtaining aqueous extracts of tea leaves (Camellia sinensis), in particular fresh tea, Pu'er tea, matcha tea or green tea, as well as tea extracts enriched with small RNAs, sugars, phenolic compounds, organic acids, theine and theanine, the cosmetic compositions comprising such extracts for use in cosmetic applications for skin care, scalp care and skin appendage care, and more particularly for protecting the skin from external damage and oxidation, combatting the signs of ageing skin, increasing sun protection, lightening the skin and improving skin hydration.
9.WO/2022/104438USE OF SUGAR CANE EXTRACTS IN THE TREATMENT OR PREVENTION OF MICROBIAL INFECTIONS AND DYSBIOSIS
WO 27.05.2022
Int.Class A61K 36/899
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
88Liliopsida (monocotyledons)
899Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
Appl.No PCT/AU2021/051395 Applicant THE PRODUCT MAKERS (AUSTRALIA) PTY LTD Inventor MITCHELL, Shane
Disclosed are methods and compositions comprising from about 0.00001 wt% to about 100 wt % of an extract derived from sugar cane for use in a variety of treatments, preventatives and control measures involving administration of an extract comprising from about 10 catechin equivalent (CE) g/L to about 50 CE g/L of polyphenols or from about 100 CE mg/g to about 500 CE mg/g of polyphenols to a subject. These treatments and preventative measures include antimicrobial activity, especially against respiratory viruses in humans as well as treatments for microsporidial infections, such as EHP in shrimps and prawns. Control measures include the reduction of methane generation in ruminants. Use of these compositions, for example in dairy cows, improves the health of the cows by minimizing mastitis whilst enhancing milk yield.
10.WO/2022/104810SALVIA PLEBIA AND SCUTELLARIAE RADIX COMPOUND ACNE CREAM, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
WO 27.05.2022
Int.Class A61K 36/539
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
539Scutellaria (skullcap)
Appl.No PCT/CN2020/130963 Applicant SOOCHOW UNIVERSITY Inventor YAO, Jialu
A Salvia plebia and Scutellariae Radix compound acne cream, a preparation method therefor and an application thereof. Stearic acid, vaseline, lanolin, glycerol monostearate and cetyl alcohol are heated and mixed to obtain an oil phase; glycerol and triethanolamine are fusion-mixed to obtain a water phase; and the water phase, the oil phase, a Scutellariae Radix extract and a Salvia plebia extract are mixed, water is added to specified volume and the mixture is mixed uniformly to obtain the Salvia plebia and Scutellariae Radix compound acne cream. The problems of large toxic and side effects, long treatment period and drug resistance of pathogenic bacteria of existing acne-treating drugs are solved. The Chinese medicine-based cream is prepared from a novel external preparation cream, has strong skin adhesion and good biocompatibility, and can effectively facilitate drugs to penetrate stratum corneum, reach an action site and exert a curative effect. The drug bioavailability is enhanced, the drug dosage is reduced, the curative effect is guaranteed, irritation caused by excessive local drug concentration can be avoided, and the use is convenient and safe.